New vaccine aims to shield infants from 25 strains of pneumonia
NCT ID NCT06790290
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This Phase 2 trial is testing a new vaccine called IVT PCV-25 in healthy infants to see if it is safe and triggers a strong immune response. The vaccine targets 25 types of pneumococcal bacteria, which can cause serious illnesses like pneumonia and meningitis. Around 421 babies will receive either the new vaccine or an existing one, with doses given at 6, 10, and 14 weeks of age. Researchers will monitor for side effects and measure antibody levels to compare the vaccines.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 25-valent pneumococcal conjugate vaccine (IVT PCV-25)
- What this could lead to
- If successful, this vaccine could protect infants against 25 types of pneumococcal bacteria, potentially preventing more cases of pneumonia, meningitis, and bloodstream infections than current vaccines.
- What could go wrong
- This is a Phase 2 trial, so it's still early. The vaccine may not work as well as hoped, or could cause unexpected side effects. Results from 421 infants may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL DISEASE, INVASIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Grand Centennial Homes Clinic
Kawit, Cavite, Philippines
-
Health Index Multispecialty Clinic
Bacoor, Cavite, Philippines
-
University of the Philippines-National Health Institute_Doña Nena Health Center
Pasay, National Capital Region, Philippines
More trials for these conditions
Other studies related to the condition(s) this trial covers.